Band 1
Band 3
About
Provided by David Mardle
Practice Areas
David Mardle is a partner in Goodwin’s Technology and Life Sciences group and co-chair of Goodwin UK. With 20 years of experience advising on financings and M&A transactions in the life sciences and technology sectors, leveraging his significant M&A experience combined with his general corporate and capital markets expertise, David now concentrates his focus on representing emerging companies providing counsel on corporate and capital markets transactions.
Career
Prior to joining Goodwin in 2019, Mr. Mardle was a partner at Taylor Wessing LLP.
Chambers Review
UK
David Mardle maintains a destination practice for emerging technology and life sciences companies in their transactional matters. He also offers premier advice to investor clients on financings and M&A.
David Mardle has extensive experience advising clients in the life science and biotechnology sectors on significant M&A and financing matters.
Strengths
Provided by Chambers
"David is well respected in the market."
"He’s extremely well known for working on high growth innovation companies."
"David has an exceptional ability to clearly communicate and argue complex issues. His pragmatic, commercial advice is based on extensive experience."
"David is an excellent counsel on many matters, from financing to investment to commercial execution."
"David is hugely experienced and innovative in all areas."
"David is well respected in the market."
"He’s extremely well known for working on high growth innovation companies."
"David has an exceptional ability to clearly communicate and argue complex issues. His pragmatic, commercial advice is based on extensive experience."
"David is an excellent counsel on many matters, from financing to investment to commercial execution."
"David is hugely experienced and innovative in all areas."